Starkstein Sergio, Gellar Scott, Parlier Morgan, Payne Leslie, Piven Joseph
Fremantle Hospital, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia Australia ; Autism Association of Western Australia, Western Australia, WA 6008 Australia ; School of Psychiatry, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia Australia.
Fremantle Hospital, University of Western Australia, 35 Stirling Highway, Crawley, Western Australia Australia.
J Neurodev Disord. 2015;7(1):29. doi: 10.1186/s11689-015-9125-6. Epub 2015 Aug 30.
While it is now recognized that autism spectrum disorder (ASD) is typically a life-long condition, there exist only a handful of systematic studies on middle-aged and older adults with this condition.
We first performed a structured examination of parkinsonian motor signs in a hypothesis-generating, pilot study (study I) of 19 adults with ASD over 49 years of age. Observing high rates of parkinsonism in those off atypical neuroleptics (2/12, 17 %) in comparison to published population rates for Parkinson's disease and parkinsonism, we examined a second sample of 37 adults with ASD, over 39 years of age, using a structured neurological assessment for parkinsonism.
Twelve of the 37 subjects (32 %) met the diagnostic criteria for parkinsonism; however, of these, 29 subjects were on atypical neuroleptics, complicating interpretation of the findings. Two of eight (25 %) subjects not taking atypical neuroleptic medications met the criteria for parkinsonism. Combining subjects who were not currently taking atypical neuroleptic medications, across both studies, we conservatively classified 4/20 (20 %) with parkinsonism.
We find a high frequency of parkinsonism among ASD individuals older than 39 years. If high rates of parkinsonism and potentially Parkinson's disease are confirmed in subsequent studies of ASD, this observation has important implications for understanding the neurobiology of autism and treatment of manifestations in older adults. Given the prevalence of autism in school-age children, the recognition of its life-long natural history, and the recognition of the aging of western societies, these findings also support the importance of further systematic study of other aspects of older adults with autism.
虽然目前已认识到自闭症谱系障碍(ASD)通常是一种终身疾病,但针对患有这种疾病的中年及老年成年人的系统性研究却寥寥无几。
在一项针对19名年龄超过49岁的患有ASD的成年人的假设生成性初步研究(研究I)中,我们首先对帕金森运动体征进行了结构化检查。与已发表的帕金森病和帕金森综合征的人群发病率相比,我们观察到停用非典型抗精神病药物的患者中帕金森综合征的发病率较高(2/12,17%),于是我们使用针对帕金森综合征的结构化神经学评估方法,对37名年龄超过39岁的患有ASD的成年人的第二个样本进行了研究。
37名受试者中有12名(32%)符合帕金森综合征的诊断标准;然而,其中29名受试者正在服用非典型抗精神病药物,这使得研究结果的解读变得复杂。8名未服用非典型抗精神病药物的受试者中有2名(25%)符合帕金森综合征的标准。将两项研究中目前未服用非典型抗精神病药物的受试者合并后,我们保守地将4/20(20%)的受试者归类为患有帕金森综合征。
我们发现在年龄超过39岁的ASD个体中,帕金森综合征的发生率很高。如果在后续的ASD研究中证实帕金森综合征以及潜在的帕金森病的高发病率,那么这一观察结果对于理解自闭症的神经生物学以及老年人症状的治疗具有重要意义。鉴于学龄儿童中自闭症的患病率、对其终身自然病史的认识以及西方社会老龄化的现状,这些发现也支持了进一步系统研究老年自闭症患者其他方面的重要性。